AR241533A1 - Nuevos derivados de 5-bromonicotinato de 1,6-dimetil-10 alfa-metoxi-4,5,7,8,9,10-hexahidro-1h,6h-indolo(4,3-g,h)quinolin-8 beta-metilo. - Google Patents

Nuevos derivados de 5-bromonicotinato de 1,6-dimetil-10 alfa-metoxi-4,5,7,8,9,10-hexahidro-1h,6h-indolo(4,3-g,h)quinolin-8 beta-metilo.

Info

Publication number
AR241533A1
AR241533A1 AR86304332A AR30433286A AR241533A1 AR 241533 A1 AR241533 A1 AR 241533A1 AR 86304332 A AR86304332 A AR 86304332A AR 30433286 A AR30433286 A AR 30433286A AR 241533 A1 AR241533 A1 AR 241533A1
Authority
AR
Argentina
Prior art keywords
acid
salt
addition
steritized
methyllumylisergol
Prior art date
Application number
AR86304332A
Other languages
English (en)
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of AR241533A1 publication Critical patent/AR241533A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PREPARACION DE DERIVADOS DE 5-BROMONICOTINATO DE 1,6-DIMETIL 10 ALFA-METOXI 4,5,7,8,9,10-HEXAHIDRO-1H,6H-INDOLO (4,3-G,H)QUINOLIN-8 BETA-METILO (HALOGENADOS EN POSICION 2 DE FORMULA (I), DONDE XES CLORO, BROMO O YODO, Y DE SUS SALES DE ADICION DE ACIDO. SE ESTERIFICA UN 2-HALO-1- METILLUMILISERGOL DE FORMULA (II), DONDE X ES LO DEFINIDO ANTES, O UNA SAL DE ADICION DE ACIDO DE LA MISMA CON UN ESTER REACTIVO, OBTENIDO HACIENDO REACCIONAR HIDROXISUCCINIMIDA N CON ACIDO 5-BROMONICOTINICO, Y, SI SE DESEA, EN TRANSFORMAR EL DERIVADO DE LA 2-HALONICERGOLINA, ASI OBTENIDO, DE FORMULA (I), EN UNA SAL DE ADICION DE ACIDO.
AR86304332A 1985-06-21 1986-06-19 Nuevos derivados de 5-bromonicotinato de 1,6-dimetil-10 alfa-metoxi-4,5,7,8,9,10-hexahidro-1h,6h-indolo(4,3-g,h)quinolin-8 beta-metilo. AR241533A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852447A HU193782B (en) 1985-06-21 1985-06-21 Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof

Publications (1)

Publication Number Publication Date
AR241533A1 true AR241533A1 (es) 1992-08-31

Family

ID=10959403

Family Applications (1)

Application Number Title Priority Date Filing Date
AR86304332A AR241533A1 (es) 1985-06-21 1986-06-19 Nuevos derivados de 5-bromonicotinato de 1,6-dimetil-10 alfa-metoxi-4,5,7,8,9,10-hexahidro-1h,6h-indolo(4,3-g,h)quinolin-8 beta-metilo.

Country Status (30)

Country Link
US (1) US4753949A (es)
JP (1) JPS62485A (es)
CN (1) CN1015365B (es)
AR (1) AR241533A1 (es)
AT (1) AT390614B (es)
AU (1) AU594686B2 (es)
BE (1) BE904957A (es)
CH (1) CH671018A5 (es)
CS (1) CS255875B1 (es)
DD (1) DD246111A5 (es)
DE (1) DE3620647A1 (es)
DK (1) DK292086A (es)
ES (1) ES8800953A1 (es)
FI (1) FI84605C (es)
FR (1) FR2583756B1 (es)
GB (1) GB2176788B (es)
HU (1) HU193782B (es)
IL (1) IL79179A0 (es)
IN (1) IN163116B (es)
IT (1) IT1204865B (es)
LU (1) LU86485A1 (es)
NL (1) NL8601612A (es)
NO (1) NO164099C (es)
PH (1) PH24732A (es)
PL (1) PL147390B1 (es)
PT (1) PT82808B (es)
SE (1) SE463716B (es)
SU (1) SU1445557A3 (es)
YU (1) YU107986A (es)
ZA (1) ZA864633B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193781B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 10alpha-methoxy-6-methylergoline derivatives and acid additional salts thereof
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228943A (en) * 1962-06-11 1966-01-11 Lumilysergol derivatives
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
GB1513322A (en) * 1976-01-09 1978-06-07 Farmaceutici Italia Heterocyclic ergoline derivatives
YU39278B (en) * 1976-12-22 1984-10-31 Lek Tovarna Farmacevtskih Process for preparing 5-bromo nicotinic acid esters
IT1094965B (it) * 1978-04-05 1985-08-10 Corvi Mora E Procedimento di preparazione di derivati del lisergolo
ATE18223T1 (de) * 1982-04-13 1986-03-15 Erba Farmitalia Ergolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
GB8612366D0 (en) * 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
GB8615471D0 (en) * 1986-06-25 1986-07-30 Erba Farmitalia T-butyl ergoline derivatives

Also Published As

Publication number Publication date
SU1445557A3 (ru) 1988-12-15
GB8615120D0 (en) 1986-07-23
GB2176788B (en) 1989-07-26
FI862635A (fi) 1986-12-22
AU594686B2 (en) 1990-03-15
PT82808B (pt) 1988-04-21
DK292086D0 (da) 1986-06-20
NO862493D0 (no) 1986-06-20
CS255875B1 (en) 1988-03-15
CN1015365B (zh) 1992-02-05
NO862493L (no) 1986-12-22
FI84605C (fi) 1991-12-27
ES8800953A1 (es) 1987-12-16
FR2583756B1 (fr) 1990-01-12
JPS62485A (ja) 1987-01-06
US4753949A (en) 1988-06-28
AT390614B (de) 1990-06-11
AU5891686A (en) 1986-12-24
IN163116B (es) 1988-08-13
DK292086A (da) 1986-12-22
SE463716B (sv) 1991-01-14
LU86485A1 (de) 1986-12-02
PT82808A (en) 1986-07-01
NL8601612A (nl) 1987-01-16
NO164099B (no) 1990-05-21
IT1204865B (it) 1989-03-10
CH671018A5 (es) 1989-07-31
PL147390B1 (en) 1989-05-31
DE3620647A1 (de) 1987-01-02
SE8602737L (sv) 1986-12-22
GB2176788A (en) 1987-01-07
HUT41024A (en) 1987-03-30
IL79179A0 (en) 1986-09-30
HU193782B (en) 1987-11-30
IT8620873A0 (it) 1986-06-20
ES556359A0 (es) 1987-12-16
CN86104086A (zh) 1986-12-17
FI84605B (fi) 1991-09-13
FR2583756A1 (fr) 1986-12-26
BE904957A (fr) 1986-12-19
ATA168486A (de) 1989-11-15
DD246111A5 (de) 1987-05-27
ZA864633B (en) 1987-02-25
FI862635A0 (fi) 1986-06-19
JPH0529227B2 (es) 1993-04-28
PH24732A (en) 1990-10-01
SE8602737D0 (sv) 1986-06-19
YU107986A (en) 1988-04-30
NO164099C (no) 1990-08-29

Similar Documents

Publication Publication Date Title
GB1533664A (en) Imidylbenzenedicarboxylic acid derivatives which can be used in the manufacture of cross-linkable polymers
DE3582575D1 (de) Basische zubereitungen von chinoloncarbonsaeuren.
AU585910B2 (en) New salt of dicamba
BR8907108A (pt) Inseticida seguro do ponto de vista ambiental
EP0279466A3 (en) Novel naphthalene derivatives and antiallergy and anti-inflammatory pharmaceuticals
AU576449B2 (en) Nicotinic acid derivatives
ITMI931293A1 (it) Addotti oleosolubili tra disuccinimmidi ed anidridi di acidi alifatici bicarbossilici insaturi
AR241533A1 (es) Nuevos derivados de 5-bromonicotinato de 1,6-dimetil-10 alfa-metoxi-4,5,7,8,9,10-hexahidro-1h,6h-indolo(4,3-g,h)quinolin-8 beta-metilo.
ATE55991T1 (de) 2,6-substituierte pyridinverbindungen mit weiteren substituenten.
DK52082A (da) Fremgangsmaade til fremstilling af quinonderivater
IE893641L (en) SOLVATES OF A ß-LACTAM ANTIBIOTIC
DE3476879D1 (en) Process for preparing benzothiazine compounds
OA09577A (fr) Complexes de l'acide polyadenylique avec l'acide polyuridylique
ES8607205A1 (es) Procedimiento de obtencion de un ester del acido clofibrico
AU4022493A (en) 5-amino-2-phenoxysulfonanilide compound
ATE91895T1 (de) Waessrige zubereitung einer pyrido(1,2a>pyrimidinverbindung.
NO901764D0 (no) Amoniosubstituerte brodannede azabicykliske kinolon-karboksylsyrer og estere.
ES2164087T3 (es) Ester de hidrolasa tipo norbornane.
JPS6431762A (en) Dihalogenoindole derivative
FI930300A (fi) 5-Amino-1,2,4-tiadiatsol-3-yyli-iminokarbonyyliyhdiste
IT8048061A0 (it) Derivati di acido mercaptoacilpira zolidinon carbossilico dotati di attivita' ipotensiva
FI901046A0 (fi) Stabilisering av polyprenylfoereningen.
DE3163667D1 (en) Preparation of dihalovinylcyclopropane carboxylic acids
EP0284069A3 (en) Benzopyranopyridineacetic acid ester compounds and their pharmaceutical uses
AR247561A1 (es) Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico o un solvato de dicha sal